These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22100516)

  • 1. Surface energy analysis as a tool to probe the surface energy characteristics of micronized materials--a comparison with inverse gas chromatography.
    Gamble JF; Leane M; Olusanmi D; Tobyn M; Supuk E; Khoo J; Naderi M
    Int J Pharm; 2012 Jan; 422(1-2):238-44. PubMed ID: 22100516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of drug particle surface energetics and young's modulus by atomic force microscopy and inverse gas chromatography.
    Davies M; Brindley A; Chen X; Marlow M; Doughty SW; Shrubb I; Roberts CJ
    Pharm Res; 2005 Jul; 22(7):1158-66. PubMed ID: 16028017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the applicability of inverse gas chromatography to binary powdered systems: an application of surface heterogeneity profiles to understanding preferential probe-surface interactions.
    Gamble JF; Davé RN; Kiang S; Leane MM; Tobyn M; Wang SS
    Int J Pharm; 2013 Mar; 445(1-2):39-46. PubMed ID: 23380622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug.
    Puri V; Shur J; Narang AS
    Mol Pharm; 2019 Oct; 16(10):4339-4351. PubMed ID: 31454254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface Energy Determined by Inverse Gas Chromatography as a Tool to Investigate Particulate Interactions in Dry Powder Inhalers.
    Das SC; Tucker IG; Stewart PJ
    Curr Pharm Des; 2015; 21(27):3932-44. PubMed ID: 26290201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse gas chromatography a tool to follow physicochemical modifications of pharmaceutical solids: Crystal habit and particles size surface effects.
    Cares-Pacheco MG; Calvet R; Vaca-Medina G; Rouilly A; Espitalier F
    Int J Pharm; 2015 Oct; 494(1):113-26. PubMed ID: 26248145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical assessment of inverse gas chromatography as means of assessing surface free energy and acid-base interaction of pharmaceutical powders.
    Telko MJ; Hickey AJ
    J Pharm Sci; 2007 Oct; 96(10):2647-54. PubMed ID: 17518355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passivation of high-surface-energy sites of milled ibuprofen crystals via dry coating for reduced cohesion and improved flowability.
    Han X; Jallo L; To D; Ghoroi C; Davé R
    J Pharm Sci; 2013 Jul; 102(7):2282-96. PubMed ID: 23658057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface energy and interparticle forces correlations in model pMDI formulations.
    Traini D; Rogueda P; Young P; Price R
    Pharm Res; 2005 May; 22(5):816-25. PubMed ID: 15906178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface energy characteristics of toner particles by automated inverse gas chromatography.
    Seger LH; Wouters ME; Bos M; van den Berg JW; Vancso GJ
    J Chromatogr A; 2002 Sep; 969(1-2):215-27. PubMed ID: 12385393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploration of inter-relationships between contact angle, inverse phase gas chromatography and triboelectric charging data.
    Ahfat NM; Buckton G; Burrows R; Ticehurst MD
    Eur J Pharm Sci; 2000 Jan; 9(3):271-6. PubMed ID: 10594384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the development of hydrate phases as active pharmaceutical ingredients--an example.
    Feth MP; Nagel N; Baumgartner B; Bröckelmann M; Rigal D; Otto B; Spitzenberg M; Schulz M; Becker B; Fischer F; Petzoldt C
    Eur J Pharm Sci; 2011 Jan; 42(1-2):116-29. PubMed ID: 21073949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals.
    Ho R; Naderi M; Heng JY; Williams DR; Thielmann F; Bouza P; Keith AR; Thiele G; Burnett DJ
    Pharm Res; 2012 Oct; 29(10):2806-16. PubMed ID: 22872437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface characterization of salmeterol xinafoate powders by inverse gas chromatography at finite coverage.
    Tong HH; Shekunov BY; York P; Chow AH
    J Pharm Sci; 2005 Mar; 94(3):695-700. PubMed ID: 15668948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of cromolyn sodium microparticles for aerosol delivery by supercritical assisted atomization.
    Reverchon E; Adami R; Caputo G
    AAPS PharmSciTech; 2007 Dec; 8(4):E114. PubMed ID: 18181535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dispersive component of the surface free energy of powders assessed using inverse gas chromatography and contact angle measurements.
    Planinsek O; Trojak A; Srcic S
    Int J Pharm; 2001 Jun; 221(1-2):211-7. PubMed ID: 11397582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization of D-mannitol polymorphs: the challenging surface energy determination by inverse gas chromatography in the infinite dilution region.
    Cares-Pacheco MG; Vaca-Medina G; Calvet R; Espitalier F; Letourneau JJ; Rouilly A; Rodier E
    Int J Pharm; 2014 Nov; 475(1-2):69-81. PubMed ID: 25151549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations on particle surface characteristics vs. dispersion behaviour of L-leucine coated carrier-free inhalable powders.
    Raula J; Thielmann F; Naderi M; Lehto VP; Kauppinen EI
    Int J Pharm; 2010 Jan; 385(1-2):79-85. PubMed ID: 19879344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse gas chromatography: investigating whether the technique preferentially probes high energy sites for mixtures of crystalline and amorphous lactose.
    Newell HE; Buckton G
    Pharm Res; 2004 Aug; 21(8):1440-4. PubMed ID: 15359579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.